Back to Latest SignalBLOOMBERG TECH / BUSINESS

China AI Biotech Firm Raises $200 Million in Oman-Backed Round

Source: Bloomberg Tech · NOV 18, 2026

Chinese biotech upstart MegaRobo Technologies has raised nearly $200 million from investors including Oman’s sovereign wealth fund, as investors pile into companies using artificial intelligence and robotics to accelerate drug research.

IN THIS STORY
  • AI Funding

Sources

  • Read the original at Bloomberg Tech

On Bluesky

  • Beijing-based MegaRobo, which uses robotics and AI to automate lab work for biotech research, raised ~$200M; it became a unicorn after raising $300M in 2022 (Bloomberg) Main Link | Techmeme Permalink

    Techmeme (@techmeme.com) Nov 18, 2026 · 3 likes

Related on Frontier

  • Beijing-based MegaRobo, which uses robotics and AI to automate lab work for biotech research, raised ~$200M; it became a unicorn after raising $300M in 2022 (Bloomberg) Nov 18, 2026
  • London-based Boltz, which is developing AI models to speed up drug discovery, raised a $110M Series A led by Bessemer, after raising a $28M seed in 2025 (John Reynolds/Tech.eu) Nov 19, 2026
  • Sources: Leopold Aschenbrenner discussed "Situational Awareness 2.0", a reboot using leverage and outside capital, four months after Citadel rescued his fund (Financial Times) Nov 18, 2026
  • Research acceleration: The jagged frontier Nov 18, 2026
  • Majority of Workplace AI Activity Takes Place Outside Enterprise Accounts Nov 18, 2026
MORE LATEST SIGNALSIGNALS